Skip to main content
. 2021 Mar 16;4:342. doi: 10.1038/s42003-021-01870-3

Fig. 4. Amelioration of hypo-immunoreactivity by J-1012 N-glycan.

Fig. 4

a Recovery of delayed-type hypersensitivity in mouse footpad by J-1012 N-glycan. b, c Analyses of cytokine production by splenocytes from mice after 2 weeks of sepsis induction with i.v injection of OVA, J-1012 N-glycan and LPS without (b) or with anti-IL-10 mAb (c). The splenocytes were restimulated as described for 4 days. d Expression of CD62L and PD-1 of transferred DO11.10 T cells (CD4+KJ1-26+) (Supplementary Fig. 10) from mice after 2 weeks of sepsis induction with OVA, LPS and J-1012 N-glycan. The experiment was repeated twice, and compiled results are shown (right panels) (n = 6). ac Data are expressed as the mean ± SD and are representative of at least two independent experiments (n = 3). p value was determined by unpaired two-tailed Student’s t-test. N.S., not significant (p > 0.05). R.IgG, control rat IgG. SRBC sheep red blood cells.